← Leaderboards
Macrae F Linton
Vanderbilt University Medical Center
$20,130,632
Attributed
$21,194,915
Total exposure
12
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$45,902,258 · 13
By mechanism
P01$32,572,032 · 6
R01$11,893,676 · 6
U2C$1,436,550 · 1
Top collaborators
- Kasey C Vickers5 shared
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Sean Stephen Davies$8,852,206
- Valentina Kon$7,107,751
- Kasey C Vickers$9,958,246
Others in their field
Top investigators on “Atherosclerosis”
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$63,519,256
- Josef Coresh · New York University School Of Medicine$60,445,875
- Daniel James Rader · University Of Pennsylvania$50,278,074
- Howard N Hodis · University Of Southern California$49,943,399
- Gary K Owens · University Of Virginia$42,472,259
- Alan Richard Tall · Columbia University Health Sciences$38,866,887
Research focus
AtherosclerosisMacrophageHigh Density LipoproteinsCholesterolInflammationHuman DiseaseInflammatoryArterial Fatty StreakLipidsIn VivoAtheroprotectivePlasmaAtherogenesisPlayProteinsFamilial HypercholesterolemiaMediatingAntiatherogenicReverse Cholesterol TransportMediationAnti-Inflammatory AgentsCellsPhospholipidsResearch Personnel
Grant awards (68)
HDL Function in Human Disease$2,559,390
P01 · FY2025 · HL · contact PI
Lipoprotein and HDL Function Core$287,933
P01 · FY2025 · HL · contact PI
Administration and Biostatistics Core$287,933
P01 · FY2025 · HL · contact PI
Dicarbonyl Scavengers to Improve HDL Function and Reduce Atherosclerosis in FH$287,931
P01 · FY2025 · HL · contact PI
HDL Function in Human Disease$2,512,032
P01 · FY2024 · HL · contact PI
Dicarbonyl Scavengers to Improve HDL Function and Reduce Atherosclerosis in FH$452,713
P01 · FY2024 · HL · contact PI
Lipoprotein and HDL Function Core$213,801
P01 · FY2024 · HL · contact PI
Administration and Biostatistics Core$163,813
P01 · FY2024 · HL · contact PI
HDL Function in Human Disease$2,571,584
P01 · FY2023 · HL · contact PI
Dicarbonyl Scavengers to Improve HDL Function and Reduce Atherosclerosis in FH$503,016
P01 · FY2023 · HL · contact PI
Lipoprotein and HDL Function Core$237,555
P01 · FY2023 · HL · contact PI
Administration and Biostatistics Core$190,299
P01 · FY2023 · HL · contact PI
HDL Function in Human Disease$2,575,515
P01 · FY2022 · HL · contact PI
Dicarbonyl Scavengers to Improve HDL Function and Reduce Atherosclerosis in FH$506,946
P01 · FY2022 · HL · contact PI
Lipoprotein and HDL Function Core$237,554
P01 · FY2022 · HL · contact PI
Administration and Biostatistics Core$190,301
P01 · FY2022 · HL · contact PI
HDL Function in Human Disease$2,621,035
P01 · FY2021 · HL · contact PI
Dicarbonyl Scavengers to Improve HDL Function and Reduce Atherosclerosis in FH$517,273
P01 · FY2021 · HL · contact PI
Lipoprotein and HDL Function Core$237,555
P01 · FY2021 · HL · contact PI
Administration and Biostatistics Core$190,300
P01 · FY2021 · HL · contact PI
Analytical Resources Core$287,310
U2C · FY2020 · DK · contact PI
Macrophage SR-BI Regulates Autophagy, Angiogenin and tRNA-derived small RNAs$532,985
R01 · FY2019 · HL · contact PI
Analytical Resources Core$287,310
U2C · FY2019 · DK · contact PI
HDL Function in Human Disease$2,388,576
P01 · FY2018 · HL · contact PI
Macrophage SR-BI Regulates Autophagy, Angiogenin and tRNA-derived small RNAs$532,985
R01 · FY2018 · HL · contact PI
Mechanisms for Dysfunctional HDL Formation in Familial Hypercholesterolemia$489,830
P01 · FY2018 · HL · contact PI
Analytical Resources Core$287,310
U2C · FY2018 · DK · contact PI
Administrative and Biostatistics Core$185,991
P01 · FY2018 · HL · contact PI
HDL Function in Human Disease$2,388,576
P01 · FY2017 · HL · contact PI
Macrophage SR-BI Regulates Autophagy, Angiogenin and tRNA-derived small RNAs$532,985
R01 · FY2017 · HL · contact PI
Mechanisms for Dysfunctional HDL Formation in Familial Hypercholesterolemia$489,830
P01 · FY2017 · HL · contact PI
Analytical Resources Core$287,310
U2C · FY2017 · DK · contact PI
Administrative and Biostatistics Core$185,991
P01 · FY2017 · HL · contact PI
HDL Function in Human Disease$2,388,576
P01 · FY2016 · HL · contact PI
Mechanisms for Dysfunctional HDL Formation in Familial Hypercholesterolemia$489,830
P01 · FY2016 · HL · contact PI
Macrophage SR-BI Regulates Autophagy, Angiogenin and tRNA-derived small RNAs$426,986
R01 · FY2016 · HL · contact PI
Analytical Resources Core$287,310
U2C · FY2016 · DK · contact PI
Administrative and Biostatistics Core$185,991
P01 · FY2016 · HL · contact PI
Macrophage SR-BI Regulates Autophagy, Angiogenin and tRNA-derived small RNAs$102,625
R01 · FY2016 · HL · contact PI
HDL Function in Human Disease$2,337,895
P01 · FY2015 · HL · contact PI
Mechanisms for Dysfunctional HDL Formation in Familial Hypercholesterolemia$479,430
P01 · FY2015 · HL · contact PI
Administrative and Biostatistics Core$182,043
P01 · FY2015 · HL · contact PI
HDL Function in Human Disease$2,364,164
P01 · FY2014 · HL · contact PI
Mechanisms for Dysfunctional HDL Formation in Familial Hypercholesterolemia$486,212
P01 · FY2014 · HL · contact PI
Administrative and Biostatistics Core$184,618
P01 · FY2014 · HL · contact PI
Mechanisms for Dysfunctional HDL Formation in Familial Hypercholesterolemia$448,558
R01 · FY2013 · HL · contact PI
Macrophage Akt and IKKalpha signaling in apoptosis and atherosclerosis$433,276
R01 · FY2013 · HL · contact PI
Mechanisms for Dysfunctional HDL Formation in Familial Hypercholesterolemia$471,175
R01 · FY2012 · HL · contact PI
Macrophage Akt and IKKalpha signaling in apoptosis and atherosclerosis$461,375
R01 · FY2012 · HL · contact PI
Macrophage Akt and IKKalpha signaling in apoptosis and atherosclerosis$467,805
R01 · FY2011 · HL · contact PI
Macrophage Akt and IKKalpha signaling in apoptosis and atherosclerosis$469,500
R01 · FY2010 · HL · contact PI
ApoE and SR-BI as Determinants of HDL and Macrophage Function in Atherogenesis$383,750
R01 · FY2010 · HL · contact PI
Fatty Acid Binding Protein in Atherosclerosis$466,721
R01 · FY2009 · HL · contact PI
ApoE and SR-BI as Determinants of HDL and Macrophage Function in Atherogenesis$383,750
R01 · FY2009 · HL · contact PI
Fatty Acid Binding Protein in Atherosclerosis$456,199
R01 · FY2008 · HL · contact PI
ApoE and SR-BI as Determinants of HDL and Macrophage Function in Atherogenesis$383,750
R01 · FY2008 · HL · contact PI
Fatty Acid Binding Protein in Atherosclerosis$455,016
R01 · FY2007 · HL · contact PI
ApoE and SR-BI as Determinants of HDL and Macrophage Function in Atherogenesis$383,750
R01 · FY2007 · HL · contact PI
Fatty Acid Binding Protein in Atherosclerosis$458,108
R01 · FY2006 · HL · contact PI
Fatty Acid Binding Protein in Atherosclerosis$482,517
R01 · FY2005 · HL
ROLE OF FATTY ACID BINDING PROTEINS IN ATHEROSCLEROSIS$419,948
R01 · FY2003 · HL
BONE MARROW TRANSPLANTATION AND ATHEROSCLEROSIS$377,500
R01 · FY2003 · HL
ROLE OF FATTY ACID BINDING PROTEINS IN ATHEROSCLEROSIS$410,300
R01 · FY2002 · HL
BONE MARROW TRANSPLANTATION AND ATHEROSCLEROSIS$377,500
R01 · FY2002 · HL
ROLE OF FATTY ACID BINDING PROTEINS IN ATHEROSCLEROSIS$401,673
R01 · FY2001 · HL
BONE MARROW TRANSPLANTATION AND ATHEROSCLEROSIS$378,750
R01 · FY2001 · HL
ROLE OF FATTY ACID BINDING PROTEINS IN ATHEROSCLEROSIS$415,439
R01 · FY2000 · HL
BONE MARROW TRANSPLANTATION AND ATHEROSCLEROSIS$378,750
R01 · FY2000 · HL